Device fee-setting should be an EU-wide theme, says UK industry
This article was originally published in SRA
Executive Summary
The UK Association of British Healthcare Industries appreciates the reasons behind the Medicines and Healthcare products Regulatory Agency’s recent suggestion that the agency needs to raise more income. At the same time, however, the association believes that any debate about fee-setting in the medical device arena should be an EU-wide matter.